Castleark Management LLC Fate Therapeutics Inc Transaction History

Castleark Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 16, 2022	SELL	$47.84 - $64.34 $2.53 Million - $3.4 Million	-52,908 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$59.27 - $95.73 $161,214 - $260,385	-2,720 Reduced 4.89%	52,908 $3.14 Million
Q2 2021 Aug 17, 2021	SELL	$67.25 - $92.52 $191,662 - $263,682	-2,850 Reduced 4.87%	55,628 $4.83 Million
Q1 2021 May 14, 2021	BUY	$72.16 - $117.4 $1.02 Million - $1.66 Million	14,128 Added 31.86%	58,478 $4.82 Million
Q4 2020 Feb 17, 2021	BUY	$38.09 - $100.95 $1.69 Million - $4.48 Million	44,350 New	44,350 $4.03 Million

175

115M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $175M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

Stay updated on Castleark Management LLC with notifications on news.